These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Dummer R; Kohl O; Gillessen J; Kägi M; Burg G Arch Dermatol; 1993 Apr; 129(4):433-6. PubMed ID: 8466213 [TBL] [Abstract][Full Text] [Related]
26. CD7-positive Sézary syndrome with a Th1 cytokine profile. Yagi H; Tokura Y; Furukawa F; Takigawa M J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729 [TBL] [Abstract][Full Text] [Related]
27. Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. Showe LC; Fox FE; Williams D; Au K; Niu Z; Rook AH J Immunol; 1999 Oct; 163(7):4073-9. PubMed ID: 10491012 [TBL] [Abstract][Full Text] [Related]
28. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome. Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389 [TBL] [Abstract][Full Text] [Related]
30. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [TBL] [Abstract][Full Text] [Related]
31. Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis. Durgin JS; Jariwala NN; Wysocka M; Zhang KK; Maity A; Benoit B; Plastaras JP; Lewis DJ; Rosenthal JM; Teague JE; Berg S; Del Guzzo C; Kim EJ; Vittorio C; Haun PL; Samimi SS; Villasenor-Park J; Inverso J; Clark RA; Rook AH JAMA Dermatol; 2021 Jan; 157(1):90-95. PubMed ID: 33112366 [TBL] [Abstract][Full Text] [Related]
32. Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique. Ingen-Housz-Oro S; Bussel A; Flageul B; Dubertret L; Michel L; Gachelin G; Kourilsky P; Bachelez H; Musette P Transfus Apher Sci; 2003 Feb; 28(1):35-42. PubMed ID: 12620267 [TBL] [Abstract][Full Text] [Related]
33. Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome. Fritz TM; Kleinhans M; Nestle FO; Burg G; Dummer R Br J Dermatol; 1999 Jun; 140(6):1144-7. PubMed ID: 10354086 [TBL] [Abstract][Full Text] [Related]
34. Chromosomally clonal T cells in the skin, blood, or lymph nodes of two Sezary syndrome patients express CD45RA, CD45RO, CDw150, and interleukin-4, but no interleukin-2 or interferon-gamma. Karenko L; Nevala H; Raatikainen M; Franssila K; Ranki A J Invest Dermatol; 2001 Jan; 116(1):188-93. PubMed ID: 11168816 [TBL] [Abstract][Full Text] [Related]
35. Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells. Fox FE; Kubin M; Cassin M; Niu Z; Trinchieri G; Cooper KD; Rook AH J Interferon Cytokine Res; 1999 Apr; 19(4):407-15. PubMed ID: 10334392 [TBL] [Abstract][Full Text] [Related]
36. Photoactivational cytokine-modulatory action of 8-methoxypsoralen plus ultraviolet A in lymphocytes, monocytes, and cutaneous T cell lymphoma cells. Tokura Y; Seo N; Yagi H; Takigawa M Ann N Y Acad Sci; 2001 Sep; 941():185-93. PubMed ID: 11594572 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Edelson RL Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563 [TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma. Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701 [No Abstract] [Full Text] [Related]
39. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. Echchakir H; Bagot M; Dorothée G; Martinvalet D; Le Gouvello S; Boumsell L; Chouaib S; Bensussan A; Mami-Chouaib F J Invest Dermatol; 2000 Jul; 115(1):74-80. PubMed ID: 10886511 [TBL] [Abstract][Full Text] [Related]
40. Transition of Sézary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis. Assaf C; Hummel M; Zemlin M; Steinhoff M; Geilen CC; Stein H; Orfanos CE J Clin Pathol; 2004 Dec; 57(12):1325-8. PubMed ID: 15563677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]